主要成分:美洛昔康性状:本品为淡黄绿色混悬液。适应证:用于控制犬急慢性骨关节炎引起的疼痛和炎症，以及术后止痛等。用法与用量:以本品计，内服：用前充分摇匀，每1KG体重，犬首次量0.133ml，维持量0.067ml，一日1次，连用7日，因存在个体差异，请遵医嘱。规格:按C14H13N3O4S2计算(1)10ml:15mg(2)32ml:48mg包装:1瓶/盒贮藏:遮光，密封保存。新兽药注册证书号:（2014）新兽药证字31号批准文号:兽药字（2015）150252469兽药字（2015）150252468
MelocamOralSuspensionProductInfo
美昔（美洛昔康）内服混悬液产品特点
正规批文的宠物专用口服非甾体抗炎药；配备专用给药器，宠物体重全覆盖，剂量更精准，和每只宠物体重完全匹配；胃肠道刺激性小,可长期用药,6周龄以上动物均可使用；吸收迅速，组织分布广；蜂蜜香甜，液体制剂给药更方便，可拌食或直接口服；
MelocamOralSuspensionProductFeatures
MELOCAMOralSuspensionwiththefirstnationalregistrationapproval,isanon-steroidalanti-inflammatorydrug(NSAIDs)forpetuseexclusively.EquippedwithdedicatedsyringeprovidingaccuratedosewellmatchedupwithpetindividualsandcoveringtheoverallweightofpetMildirritatingtoGastrointestinaltract,anditcanbelong-termusedforanimalswithsixweeksoraboveinages.Rapiduptake,widetissuedistributionandnearly100%bioavailability.Withhoneytaste,itismoreconvenienttoadministerthesolutionbymixingitwithfoodordirectoralandimprovetreatmentcompliance.
美昔（美洛昔康）内服混悬液常见问题
1.美昔的用法用量？以本品计，内服：用前充分摇匀，每1KG体重，犬首次量0.133ml，维持量0.067ml，一日1次，连用7日，因存在个体差异，请遵医嘱。
MelocamOralSuspensionQ&A
1.DOSAGEANDADMINISTRATIONOraluse.Usethelowesteffectivedosefortheshortestdurationconsistentwithindividualresponse.Initialtreatmentisasingledoseof0.133mL/kgbodyweightonthefirstday.Treatmentistobecontinuedoncedailybyoraladministration(at24-hourintervals)atamaintenancedoseof0.067mL/kgbodyweight.Thetreatmentshouldlastatleast7days.Shakewellbeforeusethenremovecap.Theproductmaybeeithermixedwithfoodorplaceddirectlyintothemouth.Thesuspensioncanbegivenusingthemeasuringsyringeprovidedinthepackage.
美昔（美洛昔康）内服混悬液注意事项
1.不推荐用于妊娠期、泌乳期或不足6周龄的犬；2.禁用于对本品过敏的犬；3.存在肾毒性的潜在风险，请慎用于脱水、血容量减少或低血压的动物；4.禁用于胃肠道溃疡或出血，肝脏、心脏或肾脏功能受损及出血异常的犬；5.禁与糖皮质激素、其他非类固醇类消炎药或抗凝血剂合用；6.对NSAIDs过敏的人应避免接触本品。远离儿童。
MelocamOralSuspensionAttention
1.Notrecommendedforuseinpregnant,lactatingorlessthan6weeksdogs.2.Shouldnotbeusedindogswithknownhypersensitivitytotheactivesubstance.3.Shouldbeusedwithcautionindehydration,lowbloodvolumnandhypotensiveanimals,duetothepotentialriskofrenaltoxicity.4.Shouldnotbeusedindogssufferingfromgastrointestinaldisorderssuchasirritationandhaemorrhage,impairedhepatic,cardiacorrenalfunctionandhaemorrhagicdisorders.5.Donotcombinewithglucocorticoids,othernon-steroidalanti-inflammatorydrugsoranticoagulants.6.PeoplewithknownhypersensitivitytoNSAIDsshouldavoidcontactingwiththeproduct.Keepitoutthereachofchilden.